Dermata Therapeutics is a biotech company focused on developing pharmaceutical products for skin conditions. Its lead product candidate, DMT310, has completed clinical trials for moderate-to-severe acne, mild-to-moderate psoriasis, and moderate-to-severe rosacea. The company is also working on DMT410 for hyperhidrosis and aesthetic conditions.